Three batches of the Zydus Pharmaceuticals topiramate have been reported to have an error on the packaging and patient information leaflet.

Accord have told us that they have an expected re-supply date for Accord levetiracetam 250mg, 500mg and 750mg tablets of October 2025.

Epilepsy Action Northern Ireland welcomes the Regional Review of Neurology Services in Northern Ireland and urges the Department of Health to take urgent action to address the serious challenges ...

Two national NHS trials will investigate safety and effectiveness of cannabidiol (CBD) and tetrahydrocannabinol (THC) in refractory epilepsy.

NICE has published its updated guidelines on menopause today, but Epilepsy Action warns that epilepsy has been left behind in the guidance.

A new fibre-optic laser therapy for people with drug-resistant focal epilepsy will be offered on the NHS, with the first of these surgeries taking place in early 2023. This new technology allows ...

Experts at the University of Queensland have developed medicine based on spider venom which could help treat some forms of genetic epilepsy.

A ‘brain pacemaker’ aiming to reduce seizures in people with drug-resistant focal epilepsy is now available on the NHS.

Claudia now wants to share her experience about both epilepsy and autism to help others who may be going through similar experiences, and raise awareness of how epilepsy and autism can collide to get ...

A new US study finds link between gabapentin use in people with chronic nerve pain and a higher risk of dementia.

More than half of neurology and neurosurgery patients are waiting longer than 18 weeks to start treatment, according to the latest waiting time figures from the NHS. A report from NHS England showed ...

A new, seven-year project from the University of Liverpool will investigate the long-term effectiveness of VNS in refractory epilepsy.